Erratum: Organ preservation for advanced laryngeal carcinoma (Head and Neck (2006) 28 (689-696) DOI: 10.1002/hed.20387);Organ preservation for advanced laryngeal carcinoma

Head and Neck

Volumn 28, Issue 8, 2006, Pages 689-696

  Foote, Robert L ^a   Foote, R Tyler ^a   Brown, Paul D ^a   Garces, Yolanda I ^a   Okuno, Scott H ^a   Strome, Scott E ^b  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiotherapy; Laryngeal carcinoma; Organ preservation; Total laryngectomy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; CANCER RADIOTHERAPY; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX SURGERY; MALE; ORGAN PRESERVATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; VOCAL CORD;

EID: 33746335378     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20595     Document Type: Erratum

References (14)

1. Wolf GT, Hong WK, Fisher SG, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
2. Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998;124:964-971.
3. Hillman RE, Walsh MJ, Wolf GT, et al. Functional outcomes following treatment for advanced laryngeal cancer. Ann Otol Rhinol Laryngol 1998;107:2-27.
4. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
5. Weinstein GS, Myers EN, Shapshay SM, et al. Nonsurgical treatment of laryngeal cancer. N Engl J Med 2004;350:1049-1053.
6. DeSanto LW, Lillie JC, Devine KD. Surgical salvage after radiation for laryngeal cancer. Laryngoscope 1976;86:649-657.
7. DeSanto LW. T3 glottic cancer: options and consequences of the options. Laryngoscope 1984;94:1311-1315.
8. Weber RS, Forastiere A, Rosenthal DI, Laccourreye O. Controversies in the management of advanced laryngeal squamous cell carcinoma. Cancer 2004;101:211-219.
9. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncology 1998;34:224-228.
10. Beahrs OH, Myers MH. Manual for staging of cancer (2nd ed), American Joint Committee on Cancer. Philadelphia, PA: J.B. Lippincott Company; 1983.
11. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutics in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia Press; 1949. p 191-205.
12. Foote RL, Kasperbauer JL, Okuno SH, et al. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer 2005;103:559-568.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Graner DE, Foote RL, Kasperbauer JL, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 2003;113:573-579.